SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000936392-04-000482
Filing Date
2004-05-07
Accepted
2004-05-07 16:32:34
Documents
6
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR PERIOD ENDED 3-31-04 a98772e10vq.htm 10-Q 140540
2 EXHIBIT 10.53 a98772exv10w53.txt EX-10.53 6298
3 EXHIBIT 10.54 a98772exv10w54.txt EX-10.54 10673
4 EXHIBIT 31.1 a98772exv31w1.txt EX-31.1 3821
5 EXHIBIT 31.2 a98772exv31w2.txt EX-31.2 3918
6 EXHIBIT 32.1 a98772exv32w1.txt EX-32.1 2045
  Complete submission text file 0000936392-04-000482.txt   169403
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 04789574
SIC: 2836 Biological Products, (No Diagnostic Substances)